Correlation Between Visa and Immatics Biotechnologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Visa and Immatics Biotechnologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Immatics Biotechnologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and immatics biotechnologies GmbH, you can compare the effects of market volatilities on Visa and Immatics Biotechnologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Immatics Biotechnologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Immatics Biotechnologies.

Diversification Opportunities for Visa and Immatics Biotechnologies

-0.48
  Correlation Coefficient

Very good diversification

The 3 months correlation between Visa and Immatics is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and immatics biotechnologies GmbH in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immatics Biotechnologies and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Immatics Biotechnologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immatics Biotechnologies has no effect on the direction of Visa i.e., Visa and Immatics Biotechnologies go up and down completely randomly.

Pair Corralation between Visa and Immatics Biotechnologies

Taking into account the 90-day investment horizon Visa Class A is expected to generate 0.13 times more return on investment than Immatics Biotechnologies. However, Visa Class A is 7.48 times less risky than Immatics Biotechnologies. It trades about 0.33 of its potential returns per unit of risk. immatics biotechnologies GmbH is currently generating about -0.53 per unit of risk. If you would invest  28,268  in Visa Class A on August 25, 2024 and sell it today you would earn a total of  2,724  from holding Visa Class A or generate 9.64% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy86.36%
ValuesDaily Returns

Visa Class A  vs.  immatics biotechnologies GmbH

 Performance 
       Timeline  
Visa Class A 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Visa Class A are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Visa showed solid returns over the last few months and may actually be approaching a breakup point.
Immatics Biotechnologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days immatics biotechnologies GmbH has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Visa and Immatics Biotechnologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Visa and Immatics Biotechnologies

The main advantage of trading using opposite Visa and Immatics Biotechnologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Immatics Biotechnologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immatics Biotechnologies will offset losses from the drop in Immatics Biotechnologies' long position.
The idea behind Visa Class A and immatics biotechnologies GmbH pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Fundamental Analysis
View fundamental data based on most recent published financial statements
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments